Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma

SIMPLE SUMMARY: Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). Despite the genetic heterogeneity of the disease, most patients are initially treated with a combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), but...

Descripción completa

Detalles Bibliográficos
Autores principales: Leveille, Etienne, Johnson, Nathalie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125500/
https://www.ncbi.nlm.nih.gov/pubmed/33946435
http://dx.doi.org/10.3390/cancers13092167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125500/
https://www.ncbi.nlm.nih.gov/pubmed/33946435
http://dx.doi.org/10.3390/cancers13092167

Ejemplares similares